14-day Premium Trial Subscription Try For FreeTry Free
$4.41
+0.0100 (+0.227%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 EGRX stock ended at $4.41. This is 0.227% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.54% from a day low at $4.24 to a day high of $4.60.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Eagle Pharmaceuticals prices

Date Open High Low Close Volume
Jan 19, 2022 $46.53 $47.27 $45.83 $46.40 121 500
Jan 18, 2022 $47.08 $47.72 $44.70 $46.11 273 500
Jan 14, 2022 $48.06 $48.06 $46.22 $47.21 118 300
Jan 13, 2022 $48.22 $48.63 $46.91 $47.74 158 800
Jan 12, 2022 $51.59 $51.66 $47.90 $47.98 109 200
Jan 11, 2022 $52.59 $52.85 $51.46 $51.60 62 800
Jan 10, 2022 $50.90 $52.88 $50.83 $52.60 122 200
Jan 07, 2022 $51.11 $51.67 $49.92 $50.63 52 200
Jan 06, 2022 $50.63 $52.32 $50.14 $51.42 62 500
Jan 05, 2022 $52.02 $52.98 $50.54 $50.69 101 200
Jan 04, 2022 $52.27 $52.60 $50.97 $51.52 89 635
Jan 03, 2022 $51.22 $52.57 $50.47 $52.40 83 049
Dec 31, 2021 $51.44 $51.72 $50.77 $50.92 73 932
Dec 30, 2021 $52.15 $52.94 $50.99 $51.10 56 321
Dec 29, 2021 $52.79 $52.99 $51.82 $52.15 38 023
Dec 28, 2021 $54.16 $54.93 $52.70 $52.83 69 973
Dec 27, 2021 $54.83 $55.10 $54.00 $54.21 72 105
Dec 23, 2021 $55.22 $55.23 $54.19 $54.72 82 401
Dec 22, 2021 $54.13 $55.75 $53.58 $54.86 58 628
Dec 21, 2021 $55.19 $56.43 $53.99 $54.35 134 222
Dec 20, 2021 $54.09 $56.31 $53.28 $55.42 117 791
Dec 17, 2021 $52.25 $55.43 $52.04 $54.34 534 520
Dec 16, 2021 $52.34 $52.65 $50.53 $51.98 190 293
Dec 15, 2021 $46.50 $53.99 $45.09 $52.30 705 313
Dec 14, 2021 $46.77 $48.49 $46.49 $46.66 134 910
Click to get the best stock tips daily for free!

About Eagle Pharmaceuticals

Eagle Pharmaceuticals Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT